Indications for use Neupogen:
Neutropenia, febrile neutropenia in patients receiving intensive myelosuppressive cytotoxic chemotherapy for malignant diseases (with the exception of chronic myeloid leukemia and myelodysplastic syndrome), as well as neutropenia and its clinical consequences in patients receiving myeloablative therapy followed by allogeneic or autologous bone marrow transplantation;
Mobilization of peripheral blood stem cells, including after myelosuppressive therapy;
Severe congenital, intermittent or idiopathic neutropenia (absolute neutrophil count less than or equal to 0.5 x 109/l) in children and adults with a history of severe or recurrent infections;
persistent neutropenia (absolute neutrophil count less than or equal to 1.0 x 109/l) in patients with advanced HIV infection to reduce the risk of bacterial infections when other treatments cannot be used.
Active ingredient: Filgrastim
Storage temperature 4-8 degrees
Prescription medicine.
Дозировка | 30 MU/0.5 Ml, 48 MU/0.5 Ml |
---|